The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
The test can overcome the time and cost limitations of traditional culture-based drug susceptibility testing as it can more rapidly detect all mutations known to be associated with drug resistance for any TB drug in one step
A staggering 65% of the TB cases in India are in the 15-45 age group
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
Guardant360 CDx is a comprehensive genomic profiling test that utilizes blood samples from patients with advanced solid cancers
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine
Subscribe To Our Newsletter & Stay Updated
